Intersect ENT Obtains $30,000,000 Series D Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=258fafcc-4882-44d7-81cf-6e46a960c8b2&Preview=1 -
Date
2/25/2013 -
Company Name
Intersect ENT -
Mailing Address
1555 Adams Drive Menlo Park, CA 94025 -
Company Description
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. -
Website
http://www.intersectent.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series D -
Proceeds Purposes
The financing will be used to continue the rapid commercial expansion in the United States for the company’s PROPEL and PROPEL mini sinus implants and to fund clinical studies of the company’s latest product, an office-based treatment for chronic sinusitis sufferers. -
M&A Terms
-
Venture Investor
Norwest Venture Partners -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
U.S. Venture Partners -
Venture Investor
PTV Sciences -
Venture Investor
Medtronic
